(Q35586587)

9 August 2017

1 reference

title

Calreticulin is an upstream regulator of calcineurin (English)

1 reference

9 August 2017

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

3 April 2024

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

3 April 2024

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

3 April 2024

author name string

Jeffrey Lynch

1

1 reference

9 August 2017

Marek Michalak

2

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

9 August 2017

28 November 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14623303

full work available at URL

3 April 2024

https://api.elsevier.com/content/article/PII:S0006291X03016309?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

https://api.elsevier.com/content/article/PII:S0006291X03016309?httpAccept=text/plain

3 April 2024

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Biochemical and Biophysical Research Communications

3 April 2024

published in

1 reference

9 August 2017

311

1 reference

9 August 2017

4

1 reference

9 August 2017

1173-1179

1 reference

The endoplasmic reticulum: a multifunctional signaling organelle

9 August 2017

1

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Ca2+ signaling and calcium binding chaperones of the endoplasmic reticulum

3 April 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Retrograde activation of store-operated calcium channel.

3 April 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Is all of the endoplasmic reticulum created equal? The effects of the heterogeneous distribution of endoplasmic reticulum Ca2+-handling proteins

3 April 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

The endoplasmic reticulum Ca2+ store: a view from the lumen

3 April 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Calcium, a signaling molecule in the endoplasmic reticulum?

3 April 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Chaperone selection during glycoprotein translocation into the endoplasmic reticulum.

3 April 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Calreticulin: one protein, one gene, many functions.

3 April 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Functional specialization of calreticulin domains

3 April 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Calreticulin is essential for cardiac development

3 April 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Calreticulin inhibits repetitive intracellular Ca2+ waves

3 April 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Delayed activation of the store-operated calcium current induced by calreticulin overexpression in RBL-1 cells

3 April 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Overexpression of calreticulin increases the Ca2+ capacity of rapidly exchanging Ca2+ stores and reveals aspects of their lumenal microenvironment and function

3 April 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Overexpression of calreticulin increases intracellular Ca2+ storage and decreases store-operated Ca2+ influx

3 April 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Calreticulin modulates capacitative Ca2+ influx by controlling the extent of inositol 1,4,5-trisphosphate-induced Ca2+ store depletion.

3 April 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Calreticulin differentially modulates calcium uptake and release in the endoplasmic reticulum and mitochondria.

3 April 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Endoplasmic reticulum in the heart, a forgotten organelle?

3 April 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Compromised calnexin function in calreticulin-deficient cells

3 April 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Ca2+ regulation of interactions between endoplasmic reticulum chaperones.

3 April 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Compromised calnexin function in calreticulin-deficient cells

3 April 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Calcineurin: From structure to function

3 April 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Calcineurin: form and function

3 April 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

The latch region of calcineurin B is involved in both immunosuppressant-immunophilin complex docking and phosphatase activation

3 April 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Calcium, calcineurin, and the control of transcription

3 April 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Calcineurin associated with the inositol 1,4,5-trisphosphate receptor-FKBP12 complex modulates Ca2+ flux

3 April 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

The role of calcineurin in lymphocyte activation

3 April 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex

3 April 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Dual calcium ion regulation of calcineurin by calmodulin and calcineurin B

3 April 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

A calcineurin-dependent transcriptional pathway for cardiac hypertrophy

3 April 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Making matters worse for a broken heart

3 April 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Signaling in myocardial hypertrophy: life after calcineurin?

3 April 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Calcineurin and cardiac hypertrophy: where have we been? Where are we going?

3 April 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Cardiac-specific expression of calcineurin reverses embryonic lethality in calreticulin-deficient mouse

3 April 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum

3 April 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

The transcription factor NF-ATc is essential for cardiac valve formation

3 April 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy

3 April 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo

3 April 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

In vivo and in vitro inhibition of the L-type calcium current in isolated guinea-pig cardiomyocytes by the immunosuppressive agent cyclosporin A.

3 April 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Activation and cellular localization of the cyclosporine A-sensitive transcription factor NF-AT in skeletal muscle cells

3 April 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Myopathy as possible side-effect of cyclosporin

3 April 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Strategies to reduce toxicities and improve outcomes in renal transplant recipients

3 April 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Ca2+-dependent signaling pathways in the heart: potential drug targets for cardiac disease

3 April 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Cardiac hypertrophy: the good, the bad, and the ugly

3 April 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Calreticulin reveals a critical Ca(2+) checkpoint in cardiac myofibrillogenesis.

3 April 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Calcineurin inhibitors and post-transplant hyperlipidaemias

3 April 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Long-term management of the liver transplant patient: diabetes, hyperlipidemia, and obesity

3 April 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor

3 April 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Rodent pancreatic islet cells contain the calcium-binding proteins calcineurin and calretinin

3 April 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

Pharmacological agents that directly modulate insulin secretion

3 April 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

FK506: mechanism of immunosuppression and adverse-effects

3 April 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.040

3 April 2024

Identifiers

1 reference

9 August 2017

1 reference